A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation

von Imamura, Fumio, Inoue, Takako, Kimura, Madoka, Nishino, Kazumi, Kumagai, Toru
Veröffentlicht in Respir Med Case Rep (2016)

Afatinib-induced severe esophagitis in a lung cancer patient with an activated epidermal growth factor receptor mutation: A case report

von Inoue, Takako, Kimura, Madoka, Tamiya, Motohiro, Nishino, Kazumi, Kumagai, Toru, Imamura, Fumio
Veröffentlicht in Respir Med Case Rep (2017)

Delayed pseudoprogression of lung adenocarcinoma accompanied with interstitial lung disease during chemotherapy after nivolumab treatment

von Kumagai, Toru, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Nishino, Kazumi, Imamura, Fumio
Veröffentlicht in Thorac Cancer (2017)

Pembrolizumab-induced acute thrombosis: A case report

von Kunimasa, Kei, Nishino, Kazumi, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Kumagai, Toru, Imamura, Fumio
Veröffentlicht in Medicine (Baltimore) (2018)

Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report

von Nishino, Kazumi, Kunimasa, Kei, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Kuhara, Hanako, Kumagai, Toru
Veröffentlicht in BMC Pharmacol Toxicol (2020)

Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigots

von Imamura, Fumio, Okamoto, Norio, Inoue, Takako, Uchida, Junji, Nishino, Kazumi, Kimura, Madoka, Kumagai, Toru, Okami, Jiro
Veröffentlicht in Respir Med Case Rep (2015)

Transient appearance of circulating tumor DNA associated with de novo treatment

von Kato, Kikuya, Uchida, Junji, Kukita, Yoji, Kumagai, Toru, Nishino, Kazumi, Inoue, Takako, Kimura, Madoka, Imamura, Fumio
Veröffentlicht in Sci Rep (2016)

Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment

von Imamura, Fumio, Uchida, Junji, Kukita, Yoji, Kumagai, Toru, Nishino, Kazumi, Inoue, Takako, Kimura, Madoka, Kato, Kikuya
Veröffentlicht in Oncotarget (2016)

Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment

von Uchida, Junji, Imamura, Fumio, Kukita, Yoji, Oba, Shigeyuki, Kumagai, Toru, Nishino, Kazumi, Inoue, Takako, Kimura, Madoka, Kato, Kikuya
Veröffentlicht in Cancer Sci (2016)

Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients

von Kato, Kikuya, Uchida, Junji, Kukita, Yoji, Kumagai, Toru, Nishino, Kazumi, Inoue, Takako, Kimura, Madoka, Oba, Shigeyuki, Imamura, Fumio
Veröffentlicht in Sci Rep (2016)

Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lu...

von Kimura, Madoka, Imamura, Fumio, Inoue, Takako, Nishino, Kazumi, Uchida, Junji, Kumagai, Toru, Okami, Jiro, Higasiyama, Masahiko, Kamoshida, Shingo
Veröffentlicht in Mol Clin Oncol (2017)

CMET-38. IMPACT ON THE CLINICAL COURSE OF EGFR MUTATION ON BRAIN METASTASES FROM NON-SMALL-CELL LUNG CANCER FROM VIEWPOINT OF NEURO-ONCOLOGISTS

von Fujita, Yuya, Kinoshita, Manabu, Ozaki, Tomohiko, Takano, Koji, Kunimasa, Kei, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Nishino, Kazumi, Kumagai, Toru, Imamura, Fumio
Veröffentlicht in Neuro Oncol (2018)

Switching from first or second generation EGFR-TKI to osimertinib in EGFR mutation-positive NSCLC

von Imamura, Fumio, Inoue, Takako, Kunimasa, Kei, Kubota, Aki, Kuhara, Hanako, Tamiya, Motohiro, Nishino, Kazumi, Kimura, Madoka, Kuno, Kika, Kawachi, Hayato, Kumagai, Toru
Veröffentlicht in Lung Cancer Manag (2020)

Nivolumab induced vitiligo-like lesions in a patient with metastatic squamous cell carcinoma of the lung

von Nishino, Kazumi, Ohe, Shuichi, Kitamura, Masanori, Kunimasa, Kei, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Kumagai, Toru, Nakatsuka, Shin-ichi, Isei, Taiki, Imamura, Fumio
Veröffentlicht in J Thorac Dis (2018)

The impact of EGFR mutation status and single brain metastasis on the survival of non-small-cell lung cancer patients with brain metastases

von Fujita, Yuya, Kinoshita, Manabu, Ozaki, Tomohiko, Takano, Koji, Kunimasa, Kei, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Nishino, Kazumi, Kumagai, Toru, Kishima, Haruhiko, Imamura, Fumio
Veröffentlicht in Neurooncol Adv (2020)

Effectiveness of EGFR tyrosine kinase inhibitors in advanced non‐small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study

von Kanazu, Masaki, Mori, Masahide, Kimura, Madoka, Nishino, Kazumi, Shiroyama, Takayuki, Nagatomo, Izumi, Ihara, Shoichi, Komuta, Kiyoshi, Suzuki, Hidekazu, Hirashima, Tomonori, Kumagai, Toru, Imamura, Fumio
Veröffentlicht in Thorac Cancer (2020)

Outcome of platinum-based chemotherapy for non-small-cell lung cancer patients with pleural dissemination detected during surgery

von KIMURA, MADOKA, MURAKAMI, HARUYASU, NAITO, TATEAKI, KENMOTSU, HIROTSUGU, TAIRA, TETSUHIKO, AKAMATSU, HIROAKI, ONO, AKIRA, IMAI, HISAO, TAKAHASHI, TOSHIAKI, ENDO, MASAHIRO, NAKAJIMA, TAKASHI, OHDE, YASUHISA, YAMAMOTO, NOBUYUKI
Veröffentlicht 2013

HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1

von Kumagai, Toru, Tomita, Yasuhiko, Nakatsuka, Shin‐ichi, Kimura, Madoka, Kunimasa, Kei, Inoue, Takako, Tamiya, Motohiro, Nishino, Kazumi, Susaki, Yoshiyuki, Kusu, Takashi, Tokunaga, Toshiteru, Okami, Jiro, Higashiyama, Masahiko, Imamura, Fumio
Veröffentlicht in Thorac Cancer (2018)

Differences in the efficacy of S-1 monotherapy according to histological type in pretreated patients with advanced non-small cell lung cancer

von Hisamatsu, Yasushi, Murakami, Haruyasu, Akamatsu, Hiroaki, Kimura, Madoka, Mori, Keita, Imai, Hisao, Ono, Akira, Shukuya, Takehito, Taira, Tetsuhiko, Kenmotsu, Hirotsugu, Naito, Tateaki, Endo, Masahiro, Nakajima, Takashi, Takahashi, Toshiaki, Yamamoto, Nobuyuki
Veröffentlicht in Thorac Cancer (2014)

Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial

von Tamiya, Motohiro, Tamiya, Akihiro, Inoue, Takako, Kimura, Madoka, Kunimasa, Kei, Nakahama, Kenji, Taniguchi, Yoshihiko, Shiroyama, Takayuki, Isa, Shun-ichi, Nishino, Kazumi, Kumagai, Toru, Suzuki, Hidekazu, Hirashima, Tomonori, Atagi, Shinji, Imamura, Fumio
Veröffentlicht in PLoS One (2018)